129 related articles for article (PubMed ID: 33625136)
1. Willingness to Pay for Surgical Treatments for Basal Cell Carcinoma: A Population-Based Cross-Sectional Study.
Kantor J
Dermatol Surg; 2021 Apr; 47(4):467-472. PubMed ID: 33625136
[TBL] [Abstract][Full Text] [Related]
2. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
3. [Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma].
Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
Actas Dermosifiliogr; 2010 Sep; 101(7):622-8. PubMed ID: 20858388
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
[TBL] [Abstract][Full Text] [Related]
5. Medical Student Decision-Making: Standard Surgical Excision or Mohs Micrographic Surgery to Manage Basal Cell Carcinoma.
Mancuso C; Morris JB; Hernandez N; Fernandez MI
J Am Osteopath Assoc; 2018 Jan; 118(1):19-25. PubMed ID: 29309088
[TBL] [Abstract][Full Text] [Related]
6. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
Muche JM; van Rengen A; Mosterd K
Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
[TBL] [Abstract][Full Text] [Related]
7. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
Lear W; Mittmann N; Barnes E; Breen D; Murray C
J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405
[TBL] [Abstract][Full Text] [Related]
8. Surgical decision making for basal-cell carcinoma of the face.
Feldman S; Pearce DJ; Williford PM
Lancet Oncol; 2008 Dec; 9(12):1119-20. PubMed ID: 19038758
[No Abstract] [Full Text] [Related]
9. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
11. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
12. Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?
Linos E; Chren MM; Stijacic Cenzer I; Covinsky KE
J Am Geriatr Soc; 2016 Aug; 64(8):1610-5. PubMed ID: 27303932
[TBL] [Abstract][Full Text] [Related]
13. Assessing the public's preference for surgical treatment of primary basal cell carcinoma: a discrete-choice experiment in the south of the Netherlands.
Essers BA; Dirksen CD; Prins MH; Neumann HA
Dermatol Surg; 2010 Dec; 36(12):1950-5. PubMed ID: 21070461
[TBL] [Abstract][Full Text] [Related]
14. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
15. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
[TBL] [Abstract][Full Text] [Related]
16. [The role of the micrographic surgery in the management of basal cell carcinoma: experience in the Department of Dermatology, at the Hassan II University Hospital, Fes, Morocco].
Gallouj S; Aqil N; Harmouch T; Mernissi FZ
Pan Afr Med J; 2019; 33():245. PubMed ID: 31692779
[TBL] [Abstract][Full Text] [Related]
17. Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance.
Sebaratnam DF; Choy B; Lee M; Paver R; Fernández Peñas P
Dermatol Surg; 2016 May; 42(5):633-8. PubMed ID: 27110895
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
19. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
20. Patients prioritize local recurrence risk over other attributes for surgical treatment of facial melanomas-Results of a stated preference survey and choice-based conjoint analysis.
Etzkorn JR; Tuttle SD; Lim I; Feit EM; Sobanko JF; Shin TM; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Aug; 79(2):210-219.e3. PubMed ID: 29505861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
